Unilateral Breast Neoplasms clinical trials
The registry lists 16 studies for Unilateral Breast Neoplasms across more than 10 countries. 3 are recruiting or about to start. 10 of them are mainly about Unilateral Breast Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-19.
Get an email when these change. Save the Unilateral Breast Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Pfizer (2) · Taipei Medical University Hospital (1) · Academic and Community Cancer Research United (1) · London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's (1) · Sunnybrook Health Sciences Centre (1) · AHS Cancer Control Alberta (1) · Grupo de investigación C.E.R (1) · OHSU Knight Cancer Institute (1)
What is being tested here
Drugs under test in Unilateral Breast Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Prifetrastat | 1 | 1 | 1 |
| Everolimus | 1 | 1 | 1 |
| Atirmociclib | 0 | 1 | 1 |
| Abemaciclib | 0 | 0 | 1 |
| Niraparib | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
Who these studies take
Of the 3 Unilateral Breast Neoplasms studies recruiting now, 3 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 2 (67%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 3 (100%) | 1 (33%) |
| 30 | 3 (100%) | 1 (33%) |
| 40 | 3 (100%) | 1 (33%) |
| 50 | 3 (100%) | 1 (33%) |
| 65 | 3 (100%) | 1 (33%) |
| 75 | 3 (100%) | 1 (33%) |
| 85 | 3 (100%) | 1 (33%) |
Across all 16 studies, recruiting or not: 13% stop at 75 or younger and 0% at 65; 13% take children; 63% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 16 of 16. search them.
- A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.RecruitingNCT07062965Phase 331 countries
- Arm Swelling Occurence in Breast Cancer Patients With Nodal Radiotherapy: Impact of Informing Them of AI-predicted RiskRecruitingNCT07187726Not applicable2 countries
- 4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers RadiotherapyRecruitingNCT05726604Not applicable1 country
- Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic DiseaseActive, not recruitingNCT06760637Phase 330 countries
- Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast CancerActive, not recruitingNCT03012100Phase 21 country
- A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary DoseCompletedNCT05142358Not applicable1 country
- Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced CardiotoxicityTerminatedNCT04044872Early Phase 11 country
- Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast CancerCompletedNCT04481113Phase 11 country
- Evaluation of the Feasibility of Developing Personalized Breast Cancer Radiotherapy Assistive Device With 3D PrintingStatus unknownNCT04929197Not applicable1 country
- Ethnic Predisposition, Risk Factors & Breast Cancer Presentation.CompletedNCT054585701 country
- Assessment of Left-sided Cardiac Sparing Through the Use of 3-dimensional Surface Matching-based Deep Inspiration Breath Hold and Active Breathing ControlCompletedNCT03459898Not applicable1 country
- Prevalence of Lymphedema in Valle Del Cauca, Colombia.Status unknownNCT049874241 country
- MIAMI Safe Surgery for Multiple Breast CancersCompletedNCT03514654Not applicable1 country
- Hybrid PET/MR Imaging of Acute Cardiac Inflammation After Left-Sided Breast Cancer RadiotherapyStatus unknownNCT037480301 country
- Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the HeartStatus unknownNCT02052102Phase 21 country
- Cosmetic and Functional Outcomes After Breast Conserving SurgeryCompletedNCT01496001Not applicable1 country